Emerging Health Innovators (EHI) Initiative
ID: 358020Type: Posted
Overview

Buyer

Advanced Research Projects Agency for Health (HHS-ARPAH)

Award Range

$1 - $700K

Eligible Applicants

Small Businesses

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358020

Additional Information

https://arpa-h.gov/engage-and-transition/emerging-health-innovators
Timeline
    Description

    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the Emerging Health Innovators (EHI) Initiative, aimed at fostering innovative biomedical and community-driven health solutions. This initiative encourages participation from small businesses and early-career investigators through two distinct tracks: Track 1 focuses on Technology-Driven Innovation for biomedical research, while Track 2 emphasizes Community-Centered Innovation addressing local health issues. Proposals will be evaluated based on scientific merit, potential impact, and cost analysis, with awards capped at $350,000 per year for two years, and a submission deadline of February 5, 2025. Interested parties can find additional information and contact the EHI Team at EHI@arpa-h.gov or visit the initiative's webpage for further details.

    Point(s) of Contact
    EHI@arpa-h.gov
    Files
    Title
    Posted
    ARPA_H_SOL_25_118_EHI_Solicitation.pdf
    The Advanced Research Projects Agency for Health (ARPA-H) is announcing the Emerging Health Innovators (EHI) Initiative through solicitation ARPA-H-SOL-25-118. This initiative aims to engage community innovators and early-career investigators to develop innovative biomedical and community-driven health solutions. Proposers can submit their solutions through two specific tracks: Track 1 focuses on Technology-Driven Innovation for biomedical research, while Track 2 emphasizes Community-Centered Innovation that addresses community health issues. The initiative has a timeline that includes a Proposers’ Day, a deadline for solution summaries, and proposed pitch presentation dates, leading to the selection and potential award of grants. Awards will be capped at $350,000 per year for two years, with an optional extension. Eligibility requirements differ across tracks, aiming to empower early-career researchers in Track 1 and community innovators in Track 2. Proposals will be evaluated based on scientific merit, potential impact, and cost analysis. Selected performers will engage in collaborative efforts with ARPA-H throughout the grant period, adhering to a structured submission and evaluation process. This initiative aligns with ARPA-H's mission to accelerate health innovation by fostering diverse expertise and solutions.
    Attachment.bin
    Similar Opportunities
    Alzheimer’s Research Program Transforming Care Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Care Award to support innovative clinical research aimed at improving care for individuals with Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity encourages community collaboration and requires projects to focus on interventions that enhance the quality of life for both patients and their caregivers. Approximately $5.2 million is available to fund around three awards, with pre-applications due by June 12, 2025, and full applications due by August 29, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Alzheimer’s Research Program Transforming Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Research Award to support innovative research aimed at reducing the risk of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages diverse applicants, including for-profit, non-profit, and academic institutions, and emphasizes the necessity of community collaboration, particularly for clinical research projects. With an estimated total program funding of $4 million, the program anticipates awarding approximately four grants, each providing up to $1 million over a maximum of three years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Personal Health Informatics for Delivering Actionable Insights to Individuals," aimed at advancing personal health informatics through innovative data collection and analysis techniques. The initiative seeks applications that provide actionable insights to individuals by integrating various health data sources, such as electronic health records and wearable devices, while emphasizing user engagement and accessibility. This funding opportunity is crucial for enhancing personal health management and fostering collaborations between research institutions and small businesses, with grants available up to $250,000 annually for projects lasting up to four years. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for January 7, 2027.
    DHA- Military Health System Research Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is offering a funding opportunity under the Military Health System Research Program (MHSRP) aimed at enhancing healthcare delivery within the Military Health System. This grant program seeks innovative research that addresses critical areas such as healthcare economics, quality, outcomes, and service member readiness, with the goal of supporting evidence-based decision-making within the Department of Defense. The total estimated funding for this program is $10 million, with an expected ten awards to be granted, and key deadlines include a Letter of Intent submission by July 9, 2025, and full proposals due by October 17, 2025. Interested applicants can reach out to the DHA MHSRP Mailbox at dha.ncr.j-9.mbx.hsr@health.mil for further information.
    Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)," aimed at enhancing research experiences for resident clinicians in training. This initiative seeks to recruit, retain, and foster the independence of clinician-investigators by providing them with essential research opportunities early in their careers, thereby supporting basic, clinical, and translational research efforts. Although applications are not currently being solicited, potential applicants are encouraged to prepare meaningful collaborations and projects in anticipation of the forthcoming Notice of Funding Opportunity (NOFO). Interested parties can reach out to Dr. David Schopfer at david.schopfer@nih.gov or by phone at 301-402-3833 for further information, with the estimated synopsis posting date on July 11, 2025, and a projected award date of May 1, 2026.
    Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator- Initiated Studies (UH3 Clincical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies," aimed at advancing research in regenerative medicine utilizing adult stem cells. This initiative, supported by the 21st Century Cures Act, encourages small businesses to develop collaborative projects, although applications are not currently being solicited. The funding will be provided through a cooperative agreement, with an estimated synopsis posting date of August 1, 2025, and a closing date for applications expected by October 21, 2025. For further inquiries, interested parties can contact Aron Marquitz, Ph.D., at aron.marquitz@nih.gov or by phone at 301-435-1240.
    Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Trailblazer Award for New and Early Stage Investigators, a federal grant aimed at fostering innovative biomedical research that integrates engineering with life sciences. This funding opportunity, under the R21 Exploratory/Developmental Research Grant mechanism, allows for up to $400,000 in direct costs over a three-year period for projects that require minimal preliminary data, encouraging high-risk, high-reward research. The initiative is designed to enhance diversity within the research community and is open to a wide range of eligible applicants, including various educational institutions and community organizations. Interested parties should note that the application submission period opens on January 16, 2025, and closes on January 8, 2026; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
    Agency for Health Care Research and Quality
    The Agency for Healthcare Research and Quality (AHRQ) has announced a Notice of Funding Opportunity (NOFO) titled "Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care," inviting research proposals that test digital healthcare interventions aimed at enhancing healthcare service delivery. The initiative seeks to support projects that utilize the R21/R33 Phased Innovation Award mechanism, allowing for up to two years of funding for initial developmental activities and up to three years for expanded efforts, with budget caps of $280,000 for the R21 phase and $720,000 for the R33 phase. This funding opportunity emphasizes the importance of advancing digital healthcare solutions, including artificial intelligence and patient-centered technologies, to improve quality, equity, and patient engagement in clinical settings. Interested applicants must submit their proposals by October 16, 2024, and can direct inquiries to GrantQueries@ahrq.hhs.gov for further information.
    SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)
    Advanced Research Projects Agency Energy
    The Advanced Research Projects Agency - Energy (ARPA-E) is offering a funding opportunity titled "SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)" aimed at supporting innovative energy research and development projects. This grant program encourages the submission of transformative ideas that can lead to significant advancements in energy technologies, with a focus on projects that have the potential to create new learning curves and disrupt existing markets. With an estimated total program funding of $10 million, individual awards can range from $0 to $500,000, and the application process requires registration and submission through the ARPA-E eXCHANGE platform. Interested applicants should note that the application deadline is September 30, 2029, and for further inquiries, they can contact ARPA-E at arpa-e-co@hq.doe.gov.
    For Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR) for Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a grant opportunity under the Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR) for accessing Environmental influences on Child Health Outcomes (ECHO) Cohort data and biospecimen resources. This initiative aims to solicit applications for ancillary studies that investigate high-priority areas of maternal and child health, leveraging the extensive dataset and biospecimen resources from the ECHO Cohort, which includes longitudinal data from over 130,000 participants across the U.S. Eligible applicants, specifically small businesses, must register with the System for Award Management, eRA Commons, and grants.gov, and provide a Letter of Support from the ECHO Cohort Consortium Steering Committee along with evidence of funding to support their proposed studies. The application period is expected to open in July 2025, with an estimated award date of September 15, 2025; interested parties can contact Dr. Melissa Zajdel at melissa.zajdel@nih.gov or by phone at 301-435-5236 for further information.